BioAge Labs Inc.
- BIOA
- NASDAQ
- Biotechnology
- Metabolic Disease Therapeutics
- Aging Biology Platform
$4.84
Today −9.53%Quote Oct 16, 2026, 08:00 PM UTC
−40.17%over the last month
Max drawdown −42.8%From 1-month high −42.8%3 months −78.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$222.1M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$23.50
+385.5% from here
Floor
$4.66
3.8% below price
Where the price sits
6 analysts
Analyst range, low to high
$8.00$40.00
- Price $4.84
- Resistance $5.30
- Consensus $23.50
Analysts' average target sits about 386% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BIOAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
61
Founded
2015